Literature DB >> 21257627

What intensivists need to know about hemophagocytic syndrome: an underrecognized cause of death in adult intensive care units.

Toshimasa Okabe1, Gunjan Shah, Vinia Mendoza, Amyn Hirani, Michael Baram, Paul Marik.   

Abstract

Hemophagocytic syndrome, also known as hemophagocytic lymphohistiocytosis (HLH), is a rare and frequently fatal disorder caused by an uncontrollable and ineffective systemic immune response. Patients initially present with fever, cytopenia, and hepatosplenomegaly, and subsequently develop multiorgan failure (MOF). Hemophagocytosis can be found on biopsy specimen but is not required. Acquired forms of HLH can occur in apparently healthy adults, while children present more often with an inherited form of the disease. Since HLH often presents with sepsis-like symptoms and organ dysfunction, patients are usually treated for presumed sepsis, which inevitably leads to delayed diagnosis and treatment. Intensivists need to have a low threshold for suspecting this disorder when previously healthy individuals present with a fulminant sepsis-like syndrome, which are unresponsive to conventional treatment. We present 3 patients with HLH who were admitted to our adult medical intensive care unit (MICU) over a 2-year period with fatal outcomes and emphasize the diagnostic importance of markedly elevated serum ferritin levels and the need for tissue biopsy in making an accurate diagnosis in a timely manner.

Entities:  

Mesh:

Year:  2011        PMID: 21257627     DOI: 10.1177/0885066610393462

Source DB:  PubMed          Journal:  J Intensive Care Med        ISSN: 0885-0666            Impact factor:   3.510


  6 in total

1.  Secondary haemophagocytic lymphohistiocytosis in hospitalised COVID-19 patients as indicated by a modified HScore is infrequent and high scores do not associate with increased mortality.

Authors:  Michael R Ardern-Jones; Matt Stammers; Hang Tt Phan; Florina Borca; Anastasia Koutalopoulou; Ying Teo; James Batchelor; Trevor Smith; Andrew S Duncombe
Journal:  Clin Med (Lond)       Date:  2021-08-13       Impact factor: 5.410

Review 2.  [Hemophagocytic lymphohistiocytosis : A diagnostic challenge on the ICU].

Authors:  G Lachmann; P La Rosée; T Schenk; F M Brunkhorst; C Spies
Journal:  Anaesthesist       Date:  2016-10       Impact factor: 1.041

3.  Performance of HScore in Reactive Hemophagocytic Lymphohistiocytosis.

Authors:  Neerav Khare; Sree Rekha Jinkala; Srikanta Kanungo
Journal:  Indian J Hematol Blood Transfus       Date:  2020-09-10       Impact factor: 0.900

4.  Unexpected hemophagocytic syndrome in a post-cardiac surgery patient.

Authors:  Lisa Linthorst; Heleen Aardema; Jaap E Tulleken
Journal:  Crit Care       Date:  2011-09-05       Impact factor: 9.097

5.  Hemophagocytic Lymphohistiocytosis Complicating Systemic Sarcoidosis.

Authors:  Omar Abughanimeh; Ayman Qasrawi; Mouhanna Abu Ghanimeh
Journal:  Cureus       Date:  2018-06-19

6.  Hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus-positive diffuse large B-cell lymphoma, NOS of bone marrow-liver-spleen type: an autopsy case report.

Authors:  Hiroko Iizuka; Yosuke Mori; Noriaki Iwao; Michiaki Koike; Masaaki Noguchi
Journal:  J Clin Exp Hematop       Date:  2021-05-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.